ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

An illustration of prostate cancer-specific mortality versus deaths from competing causes in men with localized conservatively treated prostate cancer

An illustration of prostate cancer-specific mortality versus deaths from competing causes in men with localized conservatively treated prostate cancer
Proportion of patients dead from prostate cancer (dark grey), dead from other causes (light grey), at different follow-up times up to 10 years, according to baseline PSA and Gleason score, separately for patients aged 70 years or less at diagnosis and patients aged more than 70 years at diagnosis.
PSA: prostate-specific antigen.
Reprinted by permission from Macmillan Publishers Ltd: British Journal of Cancer. Cuzick J, Fisher G, Kattan MW, et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 2006; 95:1186. Copyright © 2006. https://www.nature.com/bjc/.
Graphic 134403 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟